IARC Classes 1 and 2 carcinogens are successfully identified by an alternative strategy that detects DNA-reactivity and cell transformation ability of chemicals

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 758, Issue 1-2, 2013, Pages 56-61

  Benigni, Romualdo ^a   Bossa, Cecilia ^a   Battistelli, Chiara Laura ^a   Tcheremenskaia, Olga ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Cancer; Mutagenicity; Predictive toxicology; Regulation; Structure Activity

Indexed keywords

2 METHYLANILINE; 2 NAPHTHYLAMINE; 2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AFLATOXIN B1; ARISTOLOCHIC ACID; AZATHIOPRINE; BENZIDINE; BENZO[A]PYRENE; BUSULFAN; CARCINOGEN; CHLORAMBUCIL; CHLORMETHINE; CHLORNAPHAZINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DICHROMATE POTASSIUM; DICHROMATE SODIUM; DIMETHYL SULFATE; ETHYLENE OXIDE; ETOPOSIDE; IARC CLASSES 1 CARCINOGEN; IARC CLASSES 2 CARCINOGEN; LEAD CHROMATE; METHOXSALEN; MUSTARD GAS; PHENACETIN; POTASSIUM CHROMATE; SEMUSTINE; TRICHLOROETHYLENE; UNCLASSIFIED DRUG; VINYL CHLORIDE;

AMES TEST; ANIMAL CELL; ARTICLE; BIOASSAY; CARCINOGENICITY; CELL DIFFERENTIATION; CELL TRANSFORMATION; COMPUTER MODEL; DATA BASE; DNA DETERMINATION; GOLD STANDARD; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SALMONELLA; SENSITIVITY AND SPECIFICITY;

ANIMALIA; RODENTIA; SALMONELLA;

EID: 84888008698     PISSN: 13835718     EISSN: 18793592     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2013.09.006     Document Type: Article

References (41)

1. Huff J.E., Haseman J.K., Rall D.P. Scientific concepts, value, and significance of chemical carcinogenesis studies. Annu. Rev. Pharmacol. Toxicol. 1991, 31:621-625.
2. Huff J. Value, validity, and historical development of carcinogenesis studies for predicting and confirming carcinogenic risks to humans. Carcinogenicity. Testing, Predicting, and Interpreting Chemical Effects 1999, 21-123. Marcel Dekker, Inc., New York. K.T. Kitchin (Ed.).
3. Huff J. Long-term chemical carcinogenesis bioassays predict human cancer hazards, issues, controversies, and uncertainties. Ann. N.Y. Acad. Sci. 1999, 895:56-79.
4. Hansch C., Kim D., Leo A.J., Novellino E., Silipo C., Vittoria A. Toward a quantitative comparative toxicology of organic compounds. Crit. Rev. Toxicol. 1989, 19:185-226.
5. Van Leeuwen K., Schultz T.W., Henry T., Diderich B., Veith G.D. Using chemical categories to fill data gaps in hazard assessment. SAR QSAR Environ. Res. 2009, 20:207-220.
6. Worth A.P. The role of QSAR methodology in the regulatory assessment of chemicals. Recent Advances in QSAR Studies: Methods and Applications 2010, 367-382. Springer, Heidelberg. T. Puzyn, J. Leszczynski, M.T.D. Cronin (Eds.).
7. Benigni R., Netzeva T.I., Benfenati E., Bossa C., Franke R., Helma C., Hulzebos E., Marchant C.A., Richard A.M., Woo Y.T., Yang C. The expanding role of predictive toxicology: an update on the (Q)SAR models for mutagens and carcinogens. J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev. 2007, 25:53-97.
8. EFSA Existing approaches incorporating replacement, reduction and refinement of animal testing: applicability in food and feed risk assessment. EFSA J. 2009, 1052:1-57.
9. Pfuhler S., Kirkland D.J., Kasper P., Hayashi M., Vanparys P., Carmichael P., Dertinger S.D., Easton D., Elhajouji A., Krul C., Rothfuss A., Schoening G., Smith A., Speit G., Thomas C., van Benthem J., Corvi R. Reduction of use of animals in regulatory genotoxicity testing: Identification and implementation opportunities - report from an ECVAM workshop. Mutat. Res. 2011, 680:31-42.
10. Schmidt C. Testing for carcinogens: shift from animals to automation gathers steam - slowly. J. Natl. Cancer Inst. 2009, 101:910-912.
11. Zunag V., Barroso J., Bremer S., Casati S., Ceridono M., Coecke S., Corvi R., Eskes C., Kinsner A., Pellizzer C., Prieto P., Worth A., Kreysa J. ECVAM Technical Report on the Status of Alternative Methods for Cosmetics Testing (2008-2009). A Report Prepared in the Framework of Directive 2003/15/EC (7th Amendment to the Cosmetics Directive). EUR 24413 EN. EUR - Scientific and Technical Research Series 2010, Publications Office of the European Union, Luxenbourg, ISSN 1018-5593.
12. Zeiger E. Identification of rodent carcinogens and noncarcinogens using genetic toxicity tests: premises, promises, and performance. Regulat. Pharmacol. Toxicol. 1998, 28:85-95.
13. Benigni R. Alternatives to the carcinogenicity bioassay for toxicity prediction: are we there yet?. Exp. Opin. Drug Metab. Toxicol. 2012, 8:1-11.
14. Kavlock R.J., Austin C.P., Tice R.R. Toxicity testing in the 21st century: implications for human health risk assessment. Risk Anal. 2009, 29:485-487.
15. Benigni R., Bossa C., Giuliani A., Tcheremenskaia O. Exploring in vitro/in vivo correlations: lessons learned from analyzing phase i results of U.S.EPA's ToxCast Project. J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev. 2010, 28:272-286.
16. Benigni R. Evaluation of the toxicity forecasting capability of EPA's ToxCast Phase I data: can ToxCast in vitro assays predict carcinogenicity?. J. Toxicol. Environ. Health C 2013, 31(3):201-212.
17. Benigni R., Bossa C. Alternative strategies for carcinogenicity assessment: an efficient and simplified approach based on in vitro mutagenicity and cell transformation assays. Mutagenesis 2011, 26:455-460.
18. Benigni R., Bossa C., Tcheremenskaia O. In vitro cell transformation assays for an integrated, alternative assessment of carcinogenicity: a data-based analysis. Mutagenesis 2013, 28:107-116.
19. Yamasaki H. Non-genotoxic mechanisms of carcinogenesis: studies of cell transformation and gap junctional intercellular communication. Toxicol. Lett. 1995, 77:55-61.
20. Baker S.G., Cappuccio A., Potter J.D. Research on early-stage carcinogenesis: are we approaching paradigm instability?. J. Clin. Oncol. 2010, 28:3215-3218.
21. OECD Detailed Review Paper on Cell Transformation Assays for Detection of Chemical Carcinogens. (31). OECD Series on Testing and Assessment 2007, OECD, Paris.
22. Creton S., Aardema M.J., Carmichael P., Harvey J.S., Martin F.L., Newbold R.F., O'Donovan M.R., Pant K., Poth A., Sakai A., Sasaki K., Scott A.D., Schechtman L.M., Shen R.R., Tanaka N., Yasaei H. Cell transformation assays for prediction of carcinogenic potential: state of the science and future research needs. Mutagenesis 2012, 62:93-101.
23. Maire M.A., Pant K., Phrakonkham P., Poth A., Schwind K.R., Rast C., Bruce S.W., Sly J.E., Bohnenberger S., Kunkelmann T., Schulz M., Vasseur P. Recommended protocol for the Syrian hamster embryo (SHE) cell transformation assay. Mutat. Res. 2012, 744:76-81.
24. Mortelmans K., Zeiger E. The Ames Salmonella/microsome mutagenicity assay. Mutat. Res. 2000, 455:29-60.
25. Vasseur P., Lasne C. OECD Detailed Review Paper (DRP) number 31 on "Cell Transformation Assays for Detection of Chemical Carcinogens": main results and conclusions. Mutat. Res. 2012, 744:8-11.
26. Benigni R., Battistelli C.L., Bossa C., Tcheremenskaia O., Crettaz P. New perspectives in toxicological information management, and the role of ISSTOX databases on assessing chemical mutagenicity and carcinogenicity. Mutagenesis 2013, 28:401-419.
27. Ashby J. Fundamental structural alerts to potential carcinogenicity or noncarcinogenicity. Environ. Mutagen. 1985, 7:919-921.
28. Worth A.P., Bassan A., de Brujin J., Gallegos Saliner A., Netzeva T.I., Pavan M., Patlewicz G., Tsakovska I., Eisenreich S. The role of the european chemicals bureau in promoting the regulatory use of (Q)SAR methods. SAR QSAR Environ. Res. 2007, 18:111-125.
29. Benigni R., Bossa C. Mechanisms of chemical carcinogenicity and mutagenicity: a review with implications for predictive toxicology. Chem. Rev. 2011, 111:2507-2536.
30. Benigni R., Bossa C., Tcheremenskaia O. Nongenotoxic carcinogenicity of chemicals: mechanisms of action, and early recognition through a new set of structural alerts. Chem. Rev. 2013, 113:2940-2957.
31. Sakano K., Oikawa S., Hiraku Y., Kawanishi S. Mechanism of metal-mediated DNA damage induced by a metabolite of carcinogenic acetamide. Chem. Biol. Interact. 2004, 149:52-59.
32. Denkhaus E., Salnikow K. Nickel essentiality, toxicity, and carcinogenicity. Crit. Rev. Oncol. Hematol. 2002, 42:35-56.
33. Assem F.L., Levy L.S. A review of current toxicological concerns on vanadium pentoxide and other vanadium compounds: gaps in knowledge and directions for future research. J. Toxicol. Environ. Health B Crit. Rev. 2009, 12:289-306.
34. Ashby J., Styles J.A., Anderson D. Selection of an in vitro carcinogenicity test for derivatives of the carcinogen hexamethylphosphoramide. Brit. J. Cancer 1977, 36:564-571.
35. Hernández L.G., van Steeg H., Luijten M., van Benthem J. Mechanisms of non-genotoxic carcinogens and importance of a weight of evidence approach. Mutat. Res. 2009, 682:94-109.
36. Woo Y.T. Mechanisms of action of chemical carcinogens, and their role in Structure-Activity Relationships (SAR) analysis and risk assessment. Quantitative Structure-Activity Relationship (QSAR) Models of Mutagens and Carcinogens 2003, 41-80. CRC Press, Boca Raton. R. Benigni (Ed.).
37. Mauthe R.J., Gibson D.P., Bunch R.T., Custer L. The Syrian Hamster Embryo (SHE) cell transformation assay: review of the methods and results. Toxicol. Pathol. 2001, 29:138-146.
38. Haga K., Ohno S., Yugawa T., Narisawa-Saito M., Fujita M., Sakamoto M., Galloway D.A., Kiyono T. Efficient immortalization of primary human cells by p.16INK4a-specific short hairpin RNA or Bmi-1, combined with introduction of hTERT. Cancer Sci. 2007, 98:147-154.
39. Stuard S.B., Kerckaert G.A., Lehman-McKeeman L.D. Characterisation of the metabolic capacity of Syrian hamster embryo (SHE) cells. Toxicol. Sci. 1999, 48:366.
40. Nguyen-Ba G., Vasseur P. Epigenetic events during the process of cell transformation induced by carcinogens (review). Oncol. Rep. 1999, 6:925-932.
41. Judson R., Richard A.M., Dix D., Houck K., Elloumi F., Martin M., Cathey T., Transue T., Spencer R., Wolf M. ACToR - Aggregated Computational Toxicology Resource. Toxicol. Appl. Pharmacol. 2008, 233:7-13.